RobertWilliamHallowellMD

Critical Care Medicine, Interstitial Lung Diseases

Director, Interstitial Lung Disease Program; Director, Ambulatory Pulmonary Clinic, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Hallowell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hallowell's full profile

Already have an account?

Office
55 Fruit St, Bulfinch 148
Boston, MA 02114
Phone+1 617-726-1721

Education & Training

Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Johns Hopkins UniversityResidency, Internal Medicine, 2007 - 2010
Columbia University Vagelos College of Physicians and SurgeonsClass of 2007

Certifications & Licensure

MA State Medical License 2014 - 2025
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
MD State Medical License 2010 - 2014
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

A digital therapy targeting anxiety in pulmonary fibrosis: A decentralized randomized controlled trial.
Joshua J Solomon, Robert W Hallowell, Cecilia Ganslandt, Jessica G Shull, Thomas Bengtsson
Respirology. 2024-12-03
Endobronchial Optical Coherence Tomography as a Novel Method forMicroscopic Assessment of Interstitial Lung Abnormalities.
Lida P Hariri, Amita Sharma, Sreyankar Nandy, Sarita R Berigei, Satomi Yamamoto
American Journal of Respiratory and Critical Care Medicine. 2024-09-01
3 citations
Microscopic Small Airway Abnormalities Identified in Early Idiopathic Pulmonary FibrosisUsing Endobronchial Optical Coherence Tomography.
Sarita R Berigei, Sreyankar Nandy, Satomi Yamamoto, Rebecca A Raphaely, Amalia DeCoursey
American Journal of Respiratory and Critical Care Medicine. 2024-08-15

Journal Articles

Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug-induced.
R.W Hallowell and M.R. Horton, Drugs, 3/1/2014
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis.
Zhao H, Chan-Li Y, Collins SL, Zhang Y, Hallowell RW, Mitzner W, Horton MR, BMC Pulmonary Medicine, 1/1/2014
Hyaluronan fragments induce IFNβ via a novel TLR4-TRIF-TBK1-IRF3-dependent pathway.
Black KE, Collins SL, Hagan RS, Hamblin MJ, Chan-Li Y, Hallowell RW, Powell JD, Horton MR, J Inflamm (Lond), 5/1/2013
Revisiting thalidomide: fighting with caution against idiopathic pulmonary fibrosis.
Maureen Horton and Robert Hallowell, Drugs of Today, 10/1/2012
Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia
Robert W. Hallowell, Robert M. Reed, Mostafa Fraig, Maureen R. Horton, Reda E. Girgis, Pulmonary circulation, 1/1/2012
Join now to see all

Press Mentions

BIDMC’s Research & Health News Digest – COVID-19 Special EditionMay 10th, 2020